论文部分内容阅读
2.4本研究是为评价口服米索前列醇对足月胎膜早破 (PROM)的引产效果 ,以及监测对胎儿和母亲的副反应。该研究系随机安慰剂对照试验。所有受试对象均签受试同意书。两组受试者在入选时均服一片 (即米索组服米索前列醇 10 0μg,时照组服维生素 C 5 0 mg)。如 6小时后没有发作 (即
2.4 This study was designed to evaluate the induction of oral misoprostol for term premature rupture of membranes (PROM) and to monitor side effects on fetuses and mothers. This study is a randomized placebo-controlled trial. All subjects are subject to the test consent form. Both groups took one tablet at enrollment (ie misoprostol was administered 100 μg of misoprostol and 50 mg of vitamin C was administered as a group). No attack after 6 hours (ie